Cargando…

CEFAZOLIN PROPHYLACTIC EFFICACY ON PROSTHETIC JOINT INFECTION AFTER PRIMARY HIP ARTHROPLASTY

OBJECTIVE: Perioperative deep prosthetic joint infection (PJI) is a serious postoperative complication of total hip arthroplasty (THA). We aimed to compare the efficacy of cefazolin administered within 24 and 48 h of primary THA for PJI prophylaxis. METHODS: In this retrospective study, 720 patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Kobayashi, Shunsuke, Yasu, Takeo, Tagawa, Seiji, Ogura, Takashi, Kitaoka, Akira, Matsubara, Masaaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: ATHA EDITORA 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9721432/
https://www.ncbi.nlm.nih.gov/pubmed/36506857
http://dx.doi.org/10.1590/1413-785220223002e248417
_version_ 1784843773788815360
author Kobayashi, Shunsuke
Yasu, Takeo
Tagawa, Seiji
Ogura, Takashi
Kitaoka, Akira
Matsubara, Masaaki
author_facet Kobayashi, Shunsuke
Yasu, Takeo
Tagawa, Seiji
Ogura, Takashi
Kitaoka, Akira
Matsubara, Masaaki
author_sort Kobayashi, Shunsuke
collection PubMed
description OBJECTIVE: Perioperative deep prosthetic joint infection (PJI) is a serious postoperative complication of total hip arthroplasty (THA). We aimed to compare the efficacy of cefazolin administered within 24 and 48 h of primary THA for PJI prophylaxis. METHODS: In this retrospective study, 720 patients were divided into two groups depending on whether cefazolin was administered as a single injection of 2 g twice daily within 24 (24-h group) or 48 h of surgery and the following day (48-h group). Sex, age at surgery, body mass index, co-existing diseases, blood test data, and PJI risk factors were evaluated. RESULTS: The 24- and 48-h groups included 364 and 356 patients, respectively. Diabetes mellitus was the most common risk factor for PJI in both groups. The corresponding incidence of perioperative deep PJI following primary THA was 0.55% and 0.28% in the 24- and 48-h groups, respectively. There was no significant difference in patient background characteristics between the groups. CONCLUSIONS: Cefazolin administration within 24 h of primary THA may be appropriate for perioperative deep PJI. Level of Evidence II; Retrospective study .
format Online
Article
Text
id pubmed-9721432
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher ATHA EDITORA
record_format MEDLINE/PubMed
spelling pubmed-97214322022-12-09 CEFAZOLIN PROPHYLACTIC EFFICACY ON PROSTHETIC JOINT INFECTION AFTER PRIMARY HIP ARTHROPLASTY Kobayashi, Shunsuke Yasu, Takeo Tagawa, Seiji Ogura, Takashi Kitaoka, Akira Matsubara, Masaaki Acta Ortop Bras Original Article OBJECTIVE: Perioperative deep prosthetic joint infection (PJI) is a serious postoperative complication of total hip arthroplasty (THA). We aimed to compare the efficacy of cefazolin administered within 24 and 48 h of primary THA for PJI prophylaxis. METHODS: In this retrospective study, 720 patients were divided into two groups depending on whether cefazolin was administered as a single injection of 2 g twice daily within 24 (24-h group) or 48 h of surgery and the following day (48-h group). Sex, age at surgery, body mass index, co-existing diseases, blood test data, and PJI risk factors were evaluated. RESULTS: The 24- and 48-h groups included 364 and 356 patients, respectively. Diabetes mellitus was the most common risk factor for PJI in both groups. The corresponding incidence of perioperative deep PJI following primary THA was 0.55% and 0.28% in the 24- and 48-h groups, respectively. There was no significant difference in patient background characteristics between the groups. CONCLUSIONS: Cefazolin administration within 24 h of primary THA may be appropriate for perioperative deep PJI. Level of Evidence II; Retrospective study . ATHA EDITORA 2022-12-02 /pmc/articles/PMC9721432/ /pubmed/36506857 http://dx.doi.org/10.1590/1413-785220223002e248417 Text en https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Kobayashi, Shunsuke
Yasu, Takeo
Tagawa, Seiji
Ogura, Takashi
Kitaoka, Akira
Matsubara, Masaaki
CEFAZOLIN PROPHYLACTIC EFFICACY ON PROSTHETIC JOINT INFECTION AFTER PRIMARY HIP ARTHROPLASTY
title CEFAZOLIN PROPHYLACTIC EFFICACY ON PROSTHETIC JOINT INFECTION AFTER PRIMARY HIP ARTHROPLASTY
title_full CEFAZOLIN PROPHYLACTIC EFFICACY ON PROSTHETIC JOINT INFECTION AFTER PRIMARY HIP ARTHROPLASTY
title_fullStr CEFAZOLIN PROPHYLACTIC EFFICACY ON PROSTHETIC JOINT INFECTION AFTER PRIMARY HIP ARTHROPLASTY
title_full_unstemmed CEFAZOLIN PROPHYLACTIC EFFICACY ON PROSTHETIC JOINT INFECTION AFTER PRIMARY HIP ARTHROPLASTY
title_short CEFAZOLIN PROPHYLACTIC EFFICACY ON PROSTHETIC JOINT INFECTION AFTER PRIMARY HIP ARTHROPLASTY
title_sort cefazolin prophylactic efficacy on prosthetic joint infection after primary hip arthroplasty
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9721432/
https://www.ncbi.nlm.nih.gov/pubmed/36506857
http://dx.doi.org/10.1590/1413-785220223002e248417
work_keys_str_mv AT kobayashishunsuke cefazolinprophylacticefficacyonprostheticjointinfectionafterprimaryhiparthroplasty
AT yasutakeo cefazolinprophylacticefficacyonprostheticjointinfectionafterprimaryhiparthroplasty
AT tagawaseiji cefazolinprophylacticefficacyonprostheticjointinfectionafterprimaryhiparthroplasty
AT oguratakashi cefazolinprophylacticefficacyonprostheticjointinfectionafterprimaryhiparthroplasty
AT kitaokaakira cefazolinprophylacticefficacyonprostheticjointinfectionafterprimaryhiparthroplasty
AT matsubaramasaaki cefazolinprophylacticefficacyonprostheticjointinfectionafterprimaryhiparthroplasty